For instance, we are still rolling out some divisions in Karnataka and Kerala — the reason for higher spends,” says Rajeev Juneja, 53. Industry analysts attribute Mankind’s rapid growth to its ability to penetrate markets unserved by larger companies and pitch products cheap. For the time being, the goal is to be India’s largest pharmaceutical company,” says Juneja. “They tend to bring a lot of family into the business in operational roles,” says the rival company executive quoted earlier. Our head of marketing and product management are professional hires,” says Juneja, exuding the silent confidence that’s so generic to them.

Source: Economic Times April 09, 2018 18:11 UTC